Innate Pharma

About:

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

Website: https://www.innate-pharma.com/

Twitter/X: InnatePharma

Top Investors: Societe Generale, AstraZeneca, Novo Nordisk, Ardian, Sofinnova Partners

Description:

Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.

Total Funding Amount:

$315M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Marseille, Provence-Alpes-Cote d'Azur, France

Founded Date:

1999-01-01

Founders:

Alessandro Moretta, Eric Vivier, François Romagne, Hervé Brailly, Jean Fournie, Marc Bonneville

Number of Employees:

51-100

Last Funding Date:

2022-05-02

IPO Status:

Public

© 2025 bioDAO.ai